Company Search:
Advanced Search
Sponsored Links
Brainstorm Cell Therapeutics Inc. Company Snapshot
Brainstorm Cell Therapeutics Inc. operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Brainstorm Cell Therapeutics Inc. with three other companies in this sector in the United States: CytRx Corporation (2003 sales of $94,000.00 of which 100% was Pharmaceutical Related Products), Titan Pharmaceuticals Inc ($89,000.00 of which 100% was Contract Revenue), and Cadus Corporation ($100,000.00 of which 100% was Pharmaceutical Products).

Sales Analysis.
  Stock Performance Chart for Brainstorm Cell Therapeutics Inc.
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 3.93
(Figures in U.S. Dollars)
1 Week -1.0%   13 Weeks 3.4%  
4 Weeks -2.7%   52 Weeks 28.4%  
Brainstorm Cell Therapeutics Inc. Key Data:
  Ticker: BCLI Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2003 Sales 82,889
(Year Ending Jan 2004).
Employees: 31
  Currency: U.S. Dollars Market Cap: 88,843,514
  Fiscal Yr Ends: December Shares Outstanding: 22,606,492
  Share Type: Common Closely Held Shares: 2,591,501
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.